HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

Autor: van Tilborg M; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Al Marzooqi SH; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada., Wong WWL; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada., Maan R; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Vermehren J; Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany., Maasoumy B; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Mazzulli T; Public Health of Ontario, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, ON, Canada., Bolotin S; Public Health of Ontario, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, ON, Canada., Garber G; Infection Protection and Control, Public Health Ontario Department of Medicine University of Ottawa and University of Toronto, Toronto, ON, Canada., Guerra F; Public Health of Ontario, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, ON, Canada., Flud CR; Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kowgier M; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada., Janssen HL; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada., de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Pawlotsky JM; National Reference Center for Viral Hepatitis B C and D, Department of Virology, Hôpital Henri Mondor, Université Paris-Est and INSERM U955, Créteil, France., Cloherty GA; Abbott Laboratories, Abbott Park, IL, USA., Duarte-Rojo A; Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Sarrazin C; Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany; Gastroenterology and Hepatology, St Josefs-Hospital, Wiesbaden, Germany., Wedemeyer H; Gastroenterology and Hepatology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany; Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network Sandra Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada. Electronic address: Jordan.Feld@uhn.ca.

Publikováno v: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2018 Dec; Vol. 3 (12), pp. 856-864. Date of Electronic Publication: 2018 Sep 28.

The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir-based regimens.

Autor: Maan R; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Al Marzooqi SH; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada., Klair JS; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Karkada J; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada., Cerocchi O; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada., Kowgier M; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada., Harrell SM; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Rhodes KD; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Janssen HLA; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Feld JJ; Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada., Duarte-Rojo A; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2017 Jul; Vol. 46 (1), pp. 46-55. Date of Electronic Publication: 2017 May 03.

Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy.

Autor: Al Marzooqi SH; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada., Feld JJ; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada.

Publikováno v: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Aug; Vol. 35 (8), pp. 1923-33. Date of Electronic Publication: 2015 Jun 03.

Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs.

Autor: Ponnuvel, Suresh¹ (AUTHOR), Prakash, Arul¹ (AUTHOR), Steve, Runal John¹ (AUTHOR), Doss, George Priya² (AUTHOR), Goel, Ashish³ (AUTHOR), Zachariah, Uday George³ (AUTHOR), Eapen, Chundamannil Eapen³ (AUTHOR), Rebekah, Grace⁴ (AUTHOR), Kannangai, Rajesh¹ (AUTHOR), Fletcher, Gnanadurai John¹ (AUTHOR) fletchergj@cmcvellore.ac.in, Abraham, Priya¹ (AUTHOR)

Publikováno v: PLoS ONE. 2/17/2023, Vol. 17 Issue 2, p1-13. 13p.

Meta‐analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct‐acting antivirals.

Autor: Sepúlveda‐Crespo, Daniel¹ (AUTHOR), Treviño‐Nakoura, Ana² (AUTHOR), Bellon, José M.³ (AUTHOR), Ardizone Jiménez, Beatriz¹ (AUTHOR), Jiménez‐Sousa, María A.^1,4 (AUTHOR), Fernández‐Rodríguez, Amanda^1,4 (AUTHOR), Martínez, Isidoro^1,4 (AUTHOR), Resino, Salvador^1,4 (AUTHOR) sresino@isciii.es

Publikováno v: Alimentary Pharmacology & Therapeutics. Oct2022, Vol. 56 Issue 8, p1224-1234. 11p. 3 Diagrams, 1 Chart.